CD44 and cancer: Previous studies indicate that both CD44 and HA are involved in chemotherapeutic drug resistance in many cancer types (Misra et al, 2005; Ohashi et al, 2007), but regulation of MDR by CD147 and CD44 in CaP remains to be fully defined.